Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Strand, Vibeke [1 ]
Mease, Philip J. [2 ,3 ]
McInnes, Iain B. [4 ]
Nash, Peter [5 ]
Thom, Howard [6 ]
Hunger, Matthias [7 ]
Gandhi, Kunal [8 ]
Mpofu, Shephard [9 ]
Jugl, Steffen [9 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[6] Univ Bristol, Bristol, Avon, England
[7] MAPI Grp, Munich, Germany
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1729
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Choy, Ernest H.
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Strand, Vibeke
    Betts, Keith A.
    Mittal, Manish
    Song, Jinlin
    Skup, Martha
    Joshi, Avani
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 349 - 362
  • [3] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Vibeke Strand
    Keith A. Betts
    Manish Mittal
    Jinlin Song
    Martha Skup
    Avani Joshi
    [J]. Rheumatology and Therapy, 2017, 4 : 349 - 362
  • [4] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    [J]. Rheumatology and Therapy, 2018, 5 : 99 - 122
  • [5] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Thom, Howard
    Hunger, Matthias
    Karabis, Andreas
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen M.
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 99 - 122
  • [6] Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis
    Strand, Vibeke
    McInnes, Iain
    Mease, Philip
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    Choy, Ernest
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 497 - 510
  • [7] SECUKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB UP TO 48 WEEKS USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Nash, P.
    McInnes, I. B.
    Mease, P.
    Thom, H.
    Cure, S.
    Palaka, E.
    Gandhi, K.
    Mpofu, S.
    Jugl, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 353 - 354
  • [8] Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    [J]. Rheumatology and Therapy, 2018, 5 : 595 - 595
  • [9] Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mcinnes, Iain B.
    [J]. RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 817 - 828
  • [10] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Kaul, Arvind
    Strand, Vibeke
    McInnes, Lain
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    [J]. RHEUMATOLOGY, 2018, 57
12345